Allergan Financial Statements
Allergan Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Allergan Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,403.4 | 3,938.9 | 3,063.3 |
| Gross Profit ($ mil.) | 3,642.2 | 3,265.7 | 2,487.6 |
| Operating Income ($ mil.) | 847.8 | 759.1 | 40.7 |
| Total Net Income ($ mil.) | 578.6 | 499.3 | (127.4) |
| Diluted EPS (Net Income) | 1.89 | 1.62 | (0.44) |
Allergan Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,141.3 | 1,130.8 | 1,130.8 |
| Gross Profit ($ mil.) | 951.1 | 932.5 | 932.5 |
| Operating Income ($ mil.) | 250.1 | 275.5 | 275.5 |
| Total Net Income ($ mil.) | 179.0 | 176.1 | 176.1 |
| Diluted EPS (Net Income) | 0.58 | 0.58 | 0.58 |
Allergan Stock Quote & Chart
11/06/09 16:02:00 EST •
NYSE •
59.25
•
 +0.0900
•
+0.1521 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Allergan Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 4.21 | 16.45 | 7.01 |
| Price/Earnings Ratio | 33.00 | 384.62 | 25.51 |
| Price/Book Ratio | 4.01 | 3.53 | 6.74 |
| Price/Cash Flow Ratio | 20.41 | 80.00 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Allergan Financial Ratios
Allergan Competitive Intelligence
| Alcon | Bausch & Lomb | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 6,293.7 | 2,500.0 | 63,747.0 |
| Employees | 15,400 | 13,000 | 118,700 |
| Market Cap ($ mil.) | 43,850.5 | -- | 165,490.8 |
Competitive Landscape
